| | Recommended changes to oncology clinical trial design: Revolution or evolution?Received 10 September 2007; accepted 19 September 2007. published online 05 November 2007. No abstract is available. To read the body of this article, please view the Full Text online. |
a University of Chicago, Chicago, IL, USA b Bristol-Myers Squibb, Wallingford, CT, USA c Abbott Laboratories, Abbott Park, IL, USA d Genentech, San Francisco, CA, USA e Children’s Hospital of Pennsylvania, Philadelphia, PA, USA f University of Washington, Seattle, WA, USA g MD Anderson Cancer Center, Houston, TX, USA h University of California, San Francisco, CA, USA  Corresponding author: Tel.: +1 773 702 4400; fax: +1 773 702 3969.
PII: S0959-8049(07)00737-X doi:10.1016/j.ejca.2007.09.011 © 2007 Elsevier Ltd. All rights reserved. | |
|
|
